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Summary 
Neurotoxicity through abnormal activation of mem- 
brane channels is a potential cause of neurodegenera- 
tive disease. Here we show that a gain-of-function mu- 
tation, deg.3(u662), leads to the degeneration of a 
small set of neurons in the nematode C. elegans. The 
deg.3 gene encodes a nicotinic acetylcholine receptor 
a subunit, which in the region of transmembrane do- 
main II is most similar to the neuronal ~7 subunits from 
rat and chicken. The u662 mutation changes a residue 
in the second transmembrane domain, the domain 
thought to form the channel pore. A similar change in 
the equivalent amino acid in the chick protein pro- 
duces channels that desensitize slowly. Channel hy- 
peractivity may underlie the degenerations seen in the 
C. elegans deg.3(u662) mutants, since antagonists of 
nicotinic acetylcholine receptors suppress the deg. 
3(u662) mutant phenotypes. 
Introduction 
The degeneration of specific sets of neurons is seen in a 
number of inherited human disorders (Adams and Victor, 
1989). Understanding the causes of these diseases can 
be facilitated by using model organisms such as flies and 
nematodes. For example, in the nematode Caenorhabditis 
elegans, mutations causing a vacuolated neurodegenera- 
tion have led to the identification of a family of proteins, the 
degenerins, with extensive sequence similarity to proteins 
that contribute to the amiloride-sensitive Na ÷ channel 
(Canessa et al., 1993, 1994; Lingueglia et al., 1993; Voilley 
et al., 1994). All the dominant gain-of-function mutations 
that cause neu rodegeneration in the C. elegans degenerin 
genes deg-1 (Chalfie and Wolinski, 1990; Garcia-A~overos 
et al., unpublished data) and mec-4 (Chalfie and Sulston, 
1981; Driscoll and Chalfie, 1991) affect the same residue 
in the putative pore-forming region. The position of the 
degeneration-causing mutations and the vacuolated mor- 
phology of the dying neurons suggest that channel hyper- 
activity may underlie the degenerative process (Chalfie 
and Wolinski, 1990; Driscoll and Chalfie, 1991; Garc[a- 
ASoveros et al., unpublished ata). Thus, inherited neuro- 
degeneration in C. elegans is associated with channel 
defects. In humans, Na ÷ channel defects cause hyperka- 
lemic periodic paralysis and paramyotonia congenita, CI- 
channel defects produce cystic fibrosis (Caldwell and 
Schaller, 1992), and acetylcholine receptor defects under- 
lie the congenital myasthenic syndromes (Engel, 1990). 
Here, we describe a new degeneration-causing muta- 
tion, deg-3(u662), in C. elegans, deg-3(u662), like the 
previously described degeneration-causing mutations in 
the degenerin genes, is a gain-of-function mutation that 
causes vacuolated degenerations of a small set of neu- 
rons. The deg-3 protein (DEG-3) is a nicotinic acetylcholine 
receptor subunit. Molecular and pharmacological studies 
suggest that prolonged channel opening may underlie the 
neuronal degenerations caused by the deg-3(u662) muta- 
tion. These results demonstrate that mutations in neuronal 
acetylcholine receptors can lead to death of specific neu- 
ronal populations. 
Results 
The deg.3(u662) Phenotype 
deg-3(u662) mutants display a variety of phenotypes; they 
are uncoordinated (Unc), touch insensitive to both gentle 
(Mec; Chalfie and Sulston, 1981) and harsh (Tab; Chalfie 
and Wolinski, 1990) stimuli (they are Tab only at the tail), 
and contain degenerating neurons (Deg; Chalfie and Sul- 
ston, 1981; Chalfie and Wolinski, 1990; Figure 1). The 
degenerations are similar in appearance to the vacuolar 
deaths seen in mutants defective in the C. elegans degen- 
erins (Chalfie and Sulston, 1981; Chalfie and Wolinski, 
1990; Driscoll and Chalfie, 1991; Huang and Chalfie, 1994; 
Garc[a-ASoveros et al., unpublished data). 
Several degenerating cells in u662 animals were identi- 
fied, using differential interference contrast microscopy, 
by their positions (White et al., 1986) and by the behavioral 
phenotype associated with cell absence. Specifically, the 
Mec phenotype suggests that the ALM, PLM, AVM, and 
PVM touch receptor neurons were lost (Chalfie and Suls- 
ton, 1981), and the tail Tab phenotype suggests that PVC 
interneurons were lost (Chalfie and Wolinski, 1990). Dying 
cells in the positions of these cells were seen. (The loss 
of the touch receptor neurons in u662 adults was also seen 
using an anti-MEC-7 antibody, which strongly stains the 
touch receptor neurons [Mitani et al., 1993; data not 
shown].) Some degenerations are late onset (Figure 1); 
e.g., the embryonically derived ALM and PLM touch recep- 
tor neurons die midway through the larval period. Since 
deg-3 animals are Mec at hatching, the u662 mutation 
interferes with the activity of the touch receptor neurons 
before mutant products or their effects reach a sufficient 
level to cause cell death. 
Because the degenerating cells swell to many times the 
normal cell diameter, identification of specific cells in the 
head and tail of the animal is difficult. However, we were 
also able to identify cells by examining the fluorescence 
produced from a fusion of the deg-3 upstream region (clon- 
ing of deg-3 is described below) and the coding region 
of the Aquorea victoria green fluorescent protein (GFP; 
Chalfie et al., 1994). Fluorescent cells were found at the 
same positions in GFP-expressing animals as the degen- 
erating neurons in deg-3(u662) mutants (Figure 2). Thus, 
the deg-3(u662) mutation appears to act in a cell autono- 
mous fashion. As predicted from the Tab and Mec pheno- 
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Figure 1. deg-3(u662) Degenerations 
(A) Schematic diagram of C. elegans indicating the positions of the cells affected by the deg-3(u662) mutations. Closed circles indicate cells whose 
identities have been determined, grey circles indicate cells whose identities ar  less certain, and open circles indicate the position of unidentified 
cells. Cells die at different times during development. Most degenerations are seen in first stage (L1) larvae, but the putative AVG cell dies in late 
embryos, the touch receptor neurons (ALM, PLM, AVM, PVM) die in L2-L3 larvae, and the putative PVD cells die in L3-L4 larvae. 
(B) Differential interference contrast micrograph of degenerations (arrowheads) ina newly hatched eg-3(u662) larva. Bar, 20 I~M. 
the ALM and PLM touch receptor neurons. In total, deg-3 
expression is seen in the cell bodies of a few sensory 
neurons (the touch receptor neurons, the two PVD neu- 
rons, and the six ILl neurons) and interneurons (the two 
PVC neurons and the single AVG neuron) and in a small 
number of, as yet, unidentified neurons in the head and 
tail. No ventral cord motor neurons fluoresced. Extensive 
GFP fluorescence was also seen from anterior to the first 
bulb of the pharynx to the tip of the nose. The deg-3 expres- 
sion pattern in the head, including the anterior fluores- 
cence, is similar to the deg-1 expression pattern (J. Garcfa- 
ASoveros and M. C., unpublished data). Most cells 
expressed the deg-3gfp fusion as early as the first larval 
stage (L1). However, GFP expression in the touch receptor 
Figure 2. Expression of a deg-3gfp Fusion in a L1 C. elegans Larva 
GFP fluorescence isgreen; intestinal utofluorescence is yellow. Open- 
arrow points to head fluorescence; closed arrowheads point to strongly 
fluorescing cell bodies. Bar, 20 ~.M. 
neurons occurred late in larval development (L3-L4). This 
late onset expression corresponds to the late onset degen- 
eration of these cells but not to the early onset of the Mec 
phenotype in deg-3(u662) animals. 
deg.3 Is a Gain-of-Function Mutation 
To study the normal function of deg-3, we obtained re- 
vertants of the dominant Unc phenotype associated with 
the u662 mutation. Six reversion alleles were identified 
by screening the F2 progeny of ethyl methanesulfonate 
(EMS)-mutagenized u662 animals for nonUnc animals. 
These mutations were obtained at a high frequency (at 
least 4 × 103), suggesting they are loss-of-function alleles 
(Brenner, 1974; Greenwald and Horvitz, 1980). Moreover, 
one EMS allele (u701) is deleted for most of the deg-3 
coding region (see below). These revertants are phenotyp- 
ically wild type, suggesting that deg-3 is a nonessential 
or redundant gene and that u662 is a gain-of-function mu- 
tation. (An associated lethality was sometimes een in mu- 
tageneses for additional deg-3 mutations, but did not ap- 
pear to result from the loss of deg-3 function [see 
Experimental Procedures].) Further support for the hy- 
pothesis that deg-3 encodes a nonessential or redundant 
gene came from the isolation of four transposon- 
containing mutations that revert the deg-3(u662) mutant 
phenotype to wild type. 
The reversion screens also identified two extragenic 
suppressor genes (des-211 and des-3111) needed for deg-3 
activity. These genes will be described elsewhere. 
deg-3 Encodes an Acetylcholine Receptor Subunit 
deg-3(u662) was mapped between daf-11 and sqt-3 on 
chromosome V. Correlation of the genetic and physical 
maps (Coulson et al., 1986) allowed us to choose a small 
group of cosmids (provided by A. Coulson) that potentially 
contained the deg-3 gene. These cosmids were used as 
probes on Southern blots of genomic DNAs from deg-3 
transposon insertion alleles. Two cosmids, K30B8 and 
T21D1, identified an upward shift of a 3.5 kb Hindlll frag- 
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Figure 3. deg-3 Polymorphisms 
(A) Genetic and physical map in the deg-3 region. 
(B) Defects in deg-3 mutants. Genomic cDNA was digested with Hindlll 
and EcoRI to show transposon insertions or with Hindlll to show an 
EMS-derived deletion (u701u662 is the only EMS-induced mutation 
producing an abnormal restriction pattern), when probed with the deg-3 
3.5 kb Hindlll fragment. 
ment in two transposon-containing revertants (u662u692 
and u662u693) of u662. This 3.5 kb Hindlll fragment, which 
was cloned from K30B8, identified polymorphisms in all 
four transposon-containing strains and the strain with the 
u701 mutation (Figure 3). 
A cDNA library probed with the 3.5 kb Hindlll fragment 
yielded three clones corresponding to the same message. 
Since the longest cDNA, 1.7 kb, lacked the 5' end of the 
message, we used internal primers and primers for 
C. elegans trans-spliced leaders (SL-1 or SL-2) to PCR 
amplify the 5' end. The SL-2-dependent amplification prod- 
uct was 5- to 10-fold more abundant than the SL-1- 
dependent product, suggesting that most of the trans- 
spliced message is SL-2 trans-spliced and that deg-3 may 
be part of a polycistronic transcript (Spieth et al., 1993). 
The reconstructed message is 2 kb long. A single RNA 
species of the same size is seen in Northern blots probed 
with the cDNA clones (data not shown). The complete 
cDNA encodes a 564 amino acid open reading frame (Fig- 
ure 4). This coding sequence is mutated in u662 and u701 
animals, indicating that this mRNA is the deg-3 message. 
Further support is provided by the localization of the 
transposon insertions to deg-3. Three transposon inser- 
tion alleles (u692, u693, and u704) are Tcl (Emmons et 
al., 1983) insertions located, respectively, approximately 
1, 1.5, and 0.8 kb downstream from the addition site of 
the trans-spliced leader (the u705 mutation is caused by 
the insertion of an unidentified 1.3 kb transposon). 
DEG-3 has significant similarity to (~ subunits of the neu- 
ronal nicotinic acetylcholine receptors of vertebrates 
(Numa et al., 1983). The predicted protein contains the 
signature sequence for neurotransmitter-gated channel 
proteins (Galzi et al., 1991) and the double Cys of acetyl- 
choline-binding subunits (Kao and Karlin, 1986)• Phylo- 
genic analysis suggests that deg-3 forms a distinct and 
ancient branch in the nicotinic receptor family (J. Fleming, 
GTCCCT~CC~C~G~ATATGCC~T~AC~GA~TCG~AC~TC~A~CG~A~'~C~GTCAC~¢~C~TCAC~ ~00 
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Figure 4. The deg-3 Genomic DNA Sequence and Predicted Protein 
Sequence 
Genomic sequence from the 3.5 kb Hindlll fragment is presented in 
the region of the deg-3 cDNA. The region deleted in the EMS- 
generated u701 mutation is italicized. SL-2 splice site and the poly(A) 
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Figure 5. Alignment of Protein Sequences of 
DEG-3 and the Rat and Chick e7 Subunits 
Sequences were aligned for maximal homol- 
ogy using the Gap analysis program (GCG Pro- 
grams); the 21 amino acid peptide signal se- 
quence and its cleavage site for DEG-3 were 
predicted by PC Gene, release 6.26 (Intelligen- 
etics), and is not shown. Amino acid numbering 
is of the predicted mature protein. The neuro- 
transmitter-gated channel signature (Galzi et 
al., 1991) and the two cysteines that are charac- 
teristic of Q subunits of acetylcholine receptors 
(Kao and Karlin, 1986) are underlined. The pu- 
tative transmembrane domains, as predicted for a7 protein (Couturier et al., 1990; Segu~la et al., 1993; Bertrand et al., 1993b), are boxed. DEG-3 
is 31o/0 identical to the rat (Segu~la et al., 1993) and chick proteins (Couturier et al., 1990). The identity rises to 52% in the region of TMDII (amine 
acids 260-281). 
personal communication). However, in the region of trans- 
membrane domain II (TMDII), DEG-3 most closely resem- 
bles neuronal ~7 subunits (Figure 5; Couturier et al., 1990; 
S~gu~la et al., 1993). Channels formed from Q7 homopoly- 
mers in Xenopus oocytes are highly permeable to Ca 2+ 
(Couturier et al., 1990; S~guela et al., 1993), and this ion 
selectivity is determined by three ,amino acids in TMDII 
(Bertrand et al., 1993a) that are conserved or similar in 
deg-3 (Leu-254 and Glu-237 in a7 are conserved; Leu-255 
is replaced by Met). We could not determine whether DEG- 
3-containing channels also conduct Ca 2+, since DEG-3 
does not appear to form homopolymer channels (J. Rami- 
rez-Latorre, L. Role, M. T., and M. C., unpublished data). 
Perhaps des-2 and des-3, which are needed for deg- 
3(u662) activity in vivo, may encode subunits needed for 
channel activity. 
The u662 Mutation Affects a Residue in TMDII 
The sequence of the deg-3(u662) genomic DNA has a 
single missense mutation that substitutes Asn for Ile-293 
in TMDII (Figure 5). We have confirmed that this change 
causes degeneration by transforming wild-type animals 
with in vitro mutagenized deg-3 DNA. The transformed 
animals had the same phenotypes as deg-3(u662) animals. 
Nicotinic Acetylcholine Antagonists Suppress 
the u662 Phenotype 
The u662 alteration is similar to and at the equivalent posi- 
tion to the ~7-4 (V251T) mutation in the chick ~7 subunit 
(Galzi et al., 1992; Figure 5). Both mutations change a 
hydrophobic residue to a polar one. In Xenopus oocytes, 
channels formed from homopolymers of a7-4 protein have 
high affinity for acetylcholine and desensitize slowly (Galzi 
et al., 1992). The reduced desensitization could increase 
ion influx, which could, in turn, cause the vacuolated de- 
generations seen in the deg-3(u662) mutants. To test 
whether increased channel activity underlies the u662 
phenotype, we grew deg-3(u662) animals in the presence 
of nicotinic antagonists and looked for suppression of the 
u662 touch insensitivity (Mec) phenotype (Table 1). Some 
animals that hatch in the presence of several nicotinic 
antagonists are touch sensitive, indicating that these an- 
tagonists partially suppress the degeneration of the touch 
receptor neurons. (Degeneration of the touch receptor 
neurons, which is necessary for touch response, underlies 
the Mec phenotype of deg-3(u662) animals.) Because 
touch receptor neurons die throughout the latter part of 
larval development in deg-3(u662) animals, we have not 
looked for changes in the frequency of these deaths with 
drug treatment. In addition, we have not found significant 
differences in the number of degenerations een in newly 
hatched larvae, but this negative result may be due to the 
permeability barrier provided by the egg shell. However, 
since some improvement in posture is seen in drug treated 
worms, additional arval degenerations are probably sup- 
pressed by the nicotinic antagonists. This suppression 
supports the hypothesis that hyperactivity of a nicotinic 
acetylcholine receptor underlies the deg-3(u662) phe- 
notype. 
To test whether hyperactivity of the wild-type channel 
could also cause neuronal death, we grew wild-type ani- 
mals in the presence of drugs that activate cholinergic 
receptors. Neither nicotinic agonists (levamisole [1 mM], 
nicotine [10 mM; Lewis et al., 1980], and epibatidine [10 
pM; Badio and Daly, 1994]) nor the acetylcholine sterase 
inhibitor aldicarb (200 I~M; Lewis et al., 1980) caused neu- 
Table 1. Suppression of the deg-3(u662) Mec Phenotype 
by Nicotinic Antagonists 
Drug (Concentration) % Touch 
Sensitive 
0 
d-tubocurarine (8 mM) 53 
Mecamylamine (1 mM) 45 
Hexamethonium (10 raM) 42 
~-erthroidine (1 raM) 11 
Methyllycaconite (10 ~.M) 0 
Animais were hatched and grown in the presence of different nicotinic 
antagonists and assayed for touch sensitivity in the head as last stage 
(L4) larvae or young adults. The death of the cells is not blocked by 
these treatments, so touch sensitivity cannot be tested in the tail. At 
least 100 animals were examined. Concentrations are of levels of 
drugs in the plates. Since the cuticle and intestine are considerable 
barriers to drug entry, the final concentration of these drugs in the 
nematode is unknown. D-tubocurarine was the least specific antago- 
nist, i.e., it siowed growth and movement much more than the other 
compounds in wild-type animals. Methyllycaconitine had no effect on 
wild-type or deg-3 mutants. We do not know whether this lack of effect 
was due to the absence of a putative binding site (Ward et al., 1990) 
in DEG-3 or lack of entry into the worms. 
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ronal degeneration. The lack of effect could be due to rapid 
desensitization of the wild-type receptors. In addition, 
these treatments did not advance the onset of deaths in 
deg-3(u662) mutants, suggesting that channel activation 
does not limit the onset of the deaths in these animals. 
Discussion 
The deg-3 gene has been identified by a gain-of-function 
mutation, u662, that results in neuronal degeneration. The 
loss of deg-3 activity, however, does not produce a detect- 
able mutant phenotype. This apparent wild-type null phe- 
notype could result from redundancy (another gene, or 
genes, replaces deg-3 function) or from the subtlety of 
deg-3 activity (deg-3-containing channels might modulate 
other activities). However, some clues to deg-3 function 
are provided by its expression pattern. First, deg-3 is ex- 
pressed in many of the cells that express the degenerins 
(AVG, PVC, ILl die in deg-1 mutants [Chalfie and Wolinski, 
1990], the touch receptor neurons die in mec-4 mutants 
[Chalfie and Sulston, 1981], and the PVD cells express a 
mec-lOlacZ fusion [mec-lO encodes another degenerin; 
Huang and Chalfie, 1994]). This correlation suggests the 
possibility of an interaction between the acetylcholine and 
degenerin channels. Second, since deg-3 i s expressed in 
several sensory neurons (touch receptor neurons, PVD, 
and ILl), i.e., cells stimulated by external signals, deg-3, 
by increasing internal Ca 2÷, may regulate activity or growth 
of these neurons. Acetylcholine regulates the activity of 
the hair cells of the chick cochlea (Fuchs and Murrow, 
1992), dopamine release in rat striatal slices (Giorguieff- 
Chesselet et al., 1979), and process outgrowth of retinal 
ganglion cells (Lipton et al., 1988). 
The deg-3(u662) mutation causes vacuolated cell 
deaths that are morphologically similar to those caused 
by mutations in the C. elegans degenerin genes mec-4, 
mec-lO, and deg-1 (Driscoll and Chalfie, 1991; Huang 
and Chalfie, 1994; Chalfie and Wolinski, 1990; Garcia- 
ASoveros et al., unpublished data). The analysis of the 
degenerin mutations has suggested that increased ion 
flow through the mutated channels may cause neuronal 
degeneration (Chalfie and Wolinski, 1990; Driscoll and 
Chalfie, 1991; Garcia-Ar~overos et al., unpublished data). 
This inherited neurotoxicity is similar to that caused by 
the hyperactivation of glutamate receptors (Choi et al., 
1988). Our work with deg-3 extends this model of neurode- 
generation to acetylcholine receptors. Specifically, the de- 
generations caused by deg-3(u662), a mutation affecting 
an amino acid needed for rapid desensitization of the chick 
(z7 channel (Galzi et al., 1992), and the partial suppression 
of this degeneration by nicotinic antagonists are consis- 
tent with a model whereby hyperactivation of an acetylcho- 
line receptor causes nerve cell death. 
Increased acetylcholine receptor activity can lead to a 
Ca2+-dependent degeneration of the motor endplate (Leo- 
nard and Salpeter, 1979; Leonard and Salpeter, 1982) and 
may be a cause of some of the congenital myasthenic 
syndromes (slow channel disease) in humans. Skeletal 
muscle acetylcholine receptors in some patients with con- 
genital myasthenic syndrome have increased open time 
(Engel, 1990; Engel et al., 1993), owing to mutation in 
TMDII of the ~ subunit (A. G. Engel, personal communica- 
tion). Our results suggest that defects in acetylcholine re- 
ceptors that increase activity may lead not only to tissue 
damage, but also to cell death, particularly of nerve cells. 
The relatively small size of neuronal cell bodies may lead 
to this more severe defect; the cell presumably cannot 
cope with the osmotic imbalance or Ca2÷-mediated toxicity 




Animals were grown at 20°C as described by Brenner (1974) and Way 
and Chalfie (1988). Genetic analysis followed standard procedures 
described in Brenner (1974). 
deg-3(u662) was first observed in strains carrying the DnT1 balancer 
chromosome. The u662 mutation is the dominant Unc mutation associ- 
ated with the DnT1 balance rchromosome (E Ferguson, personal com- 
munication), deg-3(u662) Was positioned on chromosome V between 
daf-11 and sqt-3, using [he following criteria. First, two of 2450 progeny 
of deg-3(u662)/unc-42(e270) daf-11(m84) were wild type; second, 22 
Dpy nonUnc and 3 R0! nonUnc progeny were found among 1619 prog- 
eny of deg-3(u662)/sqt-3(sc63) unc-76(e91 I); and third, no wild-type 
or Mec non Daf animals were found among 772 progeny of deg-3(u662)/ 
mec:9(u351)daf-11(m84) animals. 
Most EMS-derived nonUnc revertants were obtalnee in a screen oT 
F2 progeny of deg-3(u662) animals mutagenized by the method of 
Brenner (1974). Six independent, intragenic mutations were found 
among 23,000 haploid genome equivalents (heterozygotes with these 
mutations did not segregate Unc animals; at least 2000 progeny were 
observed). In addition, this screen produced one extragenic suppres- 
sor mutation, and four nonUnc mutations were not analyzed further, 
owing to sterility. Additional EMS revertants were identified among 
the progeny from a cross of mutagenized eg-3(u662);dpy-11(e224) 
hermaphrodites and wild-type (N2) males. In 8617 haploid genome 
equivalents, 7 nonUnc animals were found. All revertants obtained in 
this screen were intragenic; however, one allele cosegregated with a 
larval lethal phenotype, and two additional alleles cosegregated with 
an embryonic lethal phenotype. These lethal mutations are probably 
not stronger Ioss-of-fu nction alleles of deg-3 given the nonlethal pheno- 
type produced by the u701 deletion. The lethality may result from 
mutations that interfere with transcription of the putative polycistronic 
transcript hat encodes deg-3. 
Transposon-insertion alleles were identified by screening the 
progeny of a mut-2(r459);deg-3(u662) strain for revertants of the Unc 
phenotype (mut-2 is described in Collins et al., 1987). The deg- 
3(u662u692u707) excision allele was identified by screening the prog- 
eny of mut-2(r459);deg-3(u662u692) for Unc animals. 
Molecular Analysis 
General molecular biology methods followed the protocols in Sam- 
brook et al. (1989) and Way and Chalfie (1988). Southern blots probed 
with cosmid K30B8 labeled by random priming revealed a shift of a 
3.5 kb Hindlll fragment in transposon insertion-derived revertants of 
u882. The corresponding 3.5 kb Hindlll was cloned from K30B8 into 
pBluescript SKII- (Stratagene; producing plasmid, TU#149). TU#149, 
labeled by random priming, was used to probe genomic DNA of the 
dog-3 mutants for DNA polymorphisms. Three strongly positive cDNA 
clones, all corresponding to the same transcript, were isolated after 
screening 4 x 106 plaques from a library constructed in ZSHI_X2 (C. 
Martin and M. C., unpublished data) probed with the 3.5 kb Hindlll 
fragment from TU#149. The longest (1.7 kb) encodes a partial tran- 
script. The 5' end of the cDNA was PCR amplified from random primed 
cDNA (Clontech Laboratories, 1991) using internal primers (first round, 
GTGTCCGGAATCCAGAGATGATGG; second round, CATTCCATAT- 
TCATTGGGATTCC) and SL-1 (Krause and Hirsh, 1987) or SL-2 prim- 
ers (Huang and Hirsh, 1989). The longest cDNA was cloned into 
pBluescript SKII-. Nested deletions and internal primers were used 
to prepare both the genomic DNA and cDNA for sequencing on an 
Neuron 
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Applied Biosystems 370A DNA sequencer (Columbia University DNA 
Facility). The u701 and u662 alleles were sequenced using internal 
primers (GACAGGATATCTGCCAGAATGACG, GTGCATATCAGTA- 
TATCACTC, CAAGCAACTTCAAATTATTGG, GCGTGTTGTGCCGA- 
GCCA, CCTFACAAGTGTTGTACTTTC, GCACCATCTCTTGCTCC- 
ATC, and CAATACCAATAATGTTTTCCGTCG) from PCR-amplified 
(Sambro0k et al., 1989) genomic DNAs that were cloned into TA 
PCR1000 (Invitrogen). The positions of three transposon insertions 
were ascertained by PCR using the GACAGGATATCTGCCAGAAT- 
GACG primer (this primer is specific to the 5' end of the deg-3 mes- 
sage), and SWE-3, a Tcl-specific primer (kindly provided by S. Em- 
mons). No amplification product was made with a primer specific to 
the 3'end of the deg-3 message, CAATACCAATAATGTTTTCCGTCG, 
and SWE-3. 
Total RNA was obtained using Tri Reagent (Molecular Research 
Center), and poly(A) ÷ mRNA was selected using the PolyATtract sys- 
tem (Promega). Northern blotting procedure followed established 
methods (Sambrook et al., 1989); blots were probed with the cDNA 
insert. 
deg.3 Expression Pattern ~ 
A 12 kb Bglll genomic fragment, including the deg-3 coding sequences 
and 6 kb upstream sequence, was cloned into pBluescript SKII-. A 
Stul site was introduced by in vitro mutagenesis between the SL-2 
splice site and the first AUG of in this plasmid using a GGTTATAGGCC- 
TGAATGACGTTAA oligonuc!eotide. Using the Xbal site of the vector; 
we obtained a XbaI-Stul fragment containing the 6 kb of the deg-3 
upstream sequence, which was placed into TU#61. TU#61 is a 
C. elegans transformation vector that contains the GFP coding se- 
quence (Chalfie et al., 1994). Transformation and visualization of GFP 
followed the procedure of Chalfie et al. (1994). We did not obtain stable 
lines from animals injected with this construct, suggesting that this 
construct is harmful to the nematodes. Stable transgenic lines that 
expressed GFP were produced when the DNA 200 bp upstream of 
the deg-3 coding sequence was mutated by in-vitro mutagenesis using 
the following oligonucleotide: GCI I I IAAAAGATCTATTCACATTT- 
TGC. Identification of GFP-expressing neurons was done according 
to their position and the appearance of their processes (White et al., 
1986). 
Pharmacology 
The following drugs, dissolved in water (except aldicarb, which was 
dissolved in 700/0 ethanol, and nicotine, which is a liquid) were added to 
nematode growth media (Brenner, 1974) at the desired concentrations: 
d-tuborcurarine, hexamethonium, mecamylamine, levamisole, and 
nicotine were obtained from Sigma; methyllycaconitine, ~-erythroidine, 
and epibatidine were obtained from RBI; and aldicarb was obtained 
from Chem Service. The effects of levamisole, nicotine, mecamyi- 
amine, and aldicarb on C. elegans are described in Lewis et al. (1980). 
The effects of epibatidine are described in Badio and Daly (1994). 
The effects of the other compounds are described in Alkondon and 
Albuquerque (1993). Antagonist concentrations indicated in Table 1 
were those found most effective (best suppression with least effect 
on movement and growth of wild-type worms) or the highest possible 
(for hexamethonium, ~-erythroidine, and methyllycaconitine). Levami- 
sole, nicotine, and aldicarb were used at concentrations known to have 
effects on C. elegans (Lewis et al., 1980), and epibatidine was used 
at the highest possible concentration. Epibatidine and methyllycaconi- 
tine at the concentrations we used had no effect on wild-type worms 
and thus may not have penetrated into the animals. 
Antibody Staining 
Antibody staining was performed as described by Mitani et al. (1993). 
Twenty animals were observed; five had no mec-7 staining, and the 
rest had at least three cells missing. 
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